Skip to main content
PatientsReferrer
 
Request Appointment
Image
https://www.qscan.com.au/wp-content/uploads/2023/05/Dr-Sean-Robison.jpg

Dr Sean
Robison

BAppSC, MBBS, FRANZCR
Specialties and interests
  • Breast imaging
  • Cardiothoracic imaging
  • Musculoskeletal imaging
About

Dr Sean Robison has been a radiologist at Qscan Radiology Clinics since 2020. He obtained his Bachelor of Medicine, Bachelor of Surgery with Honours from the Australian National University in 2008. 

Sean undertook his specialist radiology training at Austin Health, Melbourne and completed a Master of Medicine (Radiology) at Melbourne University.
 

Fellowships
  • Breast Imaging, Northwest Breastscreen, Melbourne
  • Cardiothoracic Imaging, The University of Toronto, Canada
  • Musculoskeletal Imaging, ProScan Imaging, Cincinnati, USA
Other positions
  • ACT Health
  • ACT Breastscreen
  • Presented research findings at international conferences and authored publications in international journals
  • Is part of numerous multidisciplinary teams
  • Trains junior doctors and regularly contributes to the education of other medical professionals in the ACT

News & Articles

 

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.